Novartis Drug Zortress® Is First In Over A Decade Approved By FDA To Prevent ... Pharmaceutical Online (press release) 15, 2013 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress® (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant. ... of chronic renal failure was ... Label Expansion for NVS' Zortress - Analyst Blog |
